Showing results (1631-1640 of 1,694) with videos related to
Sort By:
Pageof 170
PLOS Global Public Health|April 28, 2023
Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effectiveCarly A Rodriguez, Sara Lodi, C Robert Horsburgh, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 26, 2023
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implicationsM L Rich, U Khan, C Zeng, et al.Journal of Reproductive and Infant Psychology|March 4, 2026
Labour and delivery characteristics, maternal birth satisfaction and early relational health among COVID-19 pandemic-born childrenJennifer M Warmingham, Andréane Lavallée, Marissa Lanoff, et al.BMJ Open Sport & Exercise Medicine|March 16, 2026
Knee health and associations with female-specific health, physical, psychological and social-gendered factors in women runners: the TRAIL-W cohort study protocolMelissa J Haberfield, Benjamin F Mentiplay, Danilo De Oliveira Silva, et al.Nature Communications|June 27, 2020
Extreme rainfall events alter the trophic structure in bromeliad tanks across the NeotropicsGustavo Q Romero, Nicholas A C Marino, A Andrew M MacDonald, et al.Journal of Medicinal Chemistry|November 9, 2018
Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA)Atwood K Cheung, Brian Hurley, Ryan Kerrigan, et al.Nature|September 18, 2009
Tankyrase inhibition stabilizes axin and antagonizes Wnt signallingShih-Min A Huang, Yuji M Mishina, Shanming Liu, et al.Journal of Medicinal Chemistry|February 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 SynthaseGebhard Thoma, Wolfgang Miltz, Rudolf Waelchli, et al.Nature Communications|September 7, 2019
The future of Blue Carbon sciencePeter I Macreadie, Andrea Anton, John A Raven, et al.Contemporary Clinical Trials|May 28, 2025
Protocol for a pragmatic trial to enhance quality safety, and patient experience in chronic obstructive pulmonary disease (EQuiP-COPD)Lucas M Donovan, Laura C Feemster, Margaret P Collins, et al.Pageof 170